CR11069A - Moleculas no peptidicas para la deteccion y tratamiento de tumores - Google Patents

Moleculas no peptidicas para la deteccion y tratamiento de tumores

Info

Publication number
CR11069A
CR11069A CR11069A CR11069A CR11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A CR 11069 A CR11069 A CR 11069A
Authority
CR
Costa Rica
Prior art keywords
tumors
detection
treatment
peptidic molecules
peptidic
Prior art date
Application number
CR11069A
Other languages
English (en)
Inventor
E Summerton James
Original Assignee
E Summerton James
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2007/008215 external-priority patent/WO2007117398A2/en
Application filed by E Summerton James filed Critical E Summerton James
Publication of CR11069A publication Critical patent/CR11069A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Las oncotools son composiciones para detectar y tratar tumores que contienen areas hipoxicas/acidas caracteristicas de tumores malignos de tamano superior las microscopio. Las oncotool no tienen las propiedades de ser repelidas por las cedulas en tejidos normales.
CR11069A 2007-03-30 2009-10-19 Moleculas no peptidicas para la deteccion y tratamiento de tumores CR11069A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/008215 WO2007117398A2 (en) 2006-03-30 2007-03-30 Non-peptidic molecules for detecting and treating tumors

Publications (1)

Publication Number Publication Date
CR11069A true CR11069A (es) 2009-11-20

Family

ID=39309976

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11069A CR11069A (es) 2007-03-30 2009-10-19 Moleculas no peptidicas para la deteccion y tratamiento de tumores

Country Status (5)

Country Link
AU (1) AU2007350326A1 (es)
CA (1) CA2682567A1 (es)
CR (1) CR11069A (es)
MX (1) MX2009010621A (es)
WO (1) WO2008121126A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2220004T3 (es) * 1998-04-10 2004-12-01 Pfizer Products Inc. Derivados del acido ciclobutil-ariloxiarilsulfonilaminohidroxamico.
WO2001092273A2 (en) * 2000-05-30 2001-12-06 Guilford Pharmaceuticals Inc. Benzenedicarboxylic acid derivatives
JP3953923B2 (ja) 2002-09-17 2007-08-08 カルソニックカンセイ株式会社 電動モータ及び電動モータの製造方法
US7491718B2 (en) * 2002-10-08 2009-02-17 Abbott Laboratories Sulfonamides having antiangiogenic and anticancer activity
WO2004089415A2 (en) * 2003-04-11 2004-10-21 Novo Nordisk A/S COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
US7132393B2 (en) 2005-02-28 2006-11-07 Gene Tools. Llc Transporter compositions and methods for detecting and killing cells in acidic areas of tumors
US7285529B2 (en) * 2005-02-28 2007-10-23 Gene Tools, Llc Embedder compositions and methods for detecting and killing cells in acidic areas of tumors
US20070231256A1 (en) * 2006-03-30 2007-10-04 Summerton James E Compositions and methods for detecting and treating tumors containing acidic areas
EP1998760A2 (en) * 2006-03-30 2008-12-10 James E. Summerton Non peptidic molecules for detecting and treating tumors

Also Published As

Publication number Publication date
MX2009010621A (es) 2009-12-11
AU2007350326A1 (en) 2008-10-09
CA2682567A1 (en) 2008-10-09
WO2008121126A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
CY1119751T1 (el) Υλικα και μεθοδοι για θεραπεια ή προληψη ασθενειων που σχετιζονται me her-3
LTC2100614I2 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
BRPI0716210A2 (pt) Métodos, composições e aparelhos para tratar feridas com pressões diferentes da atmosférica
CR20120202A (es) Métodos y composiciones para tratar cáncer
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
BRPI0818287A2 (pt) células dendríticas manipuladas e usos para o tratamento do câncer.
BRPI0908503A2 (pt) partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos
ATE526987T1 (de) Dr5-antikörper und deren verwendung
NO20080626L (no) Inhibitorer av fibroblastaktiverende protein alfa
ECSP11011297A (es) Proteinas ligadoras il-17
ATE547102T1 (de) Carbolin-derivate zur behandlung von krebs
BRPI0919238A2 (pt) métodos e composições para o tratamento de câncer
WO2009036188A3 (en) Insulin-like growth factor binding protein 7 for treatment of cancer
EP2298074A3 (en) Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
BRPI0812737A2 (pt) Equipamento para impedir e tratar prolapso de órgão pélvico.
BRPI0911112A2 (pt) composições e métodos para o tratamento do câncer de mama
BRPI0820802A2 (pt) Materiais e métodos para tratamento de proliferação vascular ocular patológica
BRPI0813364A2 (pt) Métodos de diagnóstico e tratamento de câncer.
WO2007033167A3 (en) Compositions and methods for detecting and treating cancer
BRPI0812932A2 (pt) Composições e métodos de tratar câncer

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)